secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001193125-21-316929
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences amends charter and bylaws upon IPO; authorizes 150M common shares
--------------------------------------------------------------------------------

- Authorized 150 million shares of common stock and 10 million shares of undesignated preferred stock.
- Eliminated all references to prior series of preferred stock from charter.
- Amended bylaws effective Oct 28, 2021: removed stockholder written consent and special meeting rights.
- Established procedures for stockholder proposals and director nominations in bylaws.
- All changes were previously disclosed in IPO registration statement S-1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312521316929/0001193125-21-316929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312521316929/d211948d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-316929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer